OSAIC HOLDINGS, INC. - CYTOMX THERAPEUTICS INC ownership

CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of CYTOMX THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$28,551
+16.2%
15,3500.0%0.00%
Q1 2023$24,560
-1.8%
15,350
-0.1%
0.00%
Q4 2022$25,000
+13.6%
15,3640.0%0.00%
Q3 2022$22,000
-21.4%
15,3640.0%0.00%
Q2 2022$28,000
+2700.0%
15,364
+4627.4%
0.00%
Q1 2022$1,000325
+2221.4%
0.00%
Q4 2021$014
-6.7%
0.00%
Q3 2021$015
-67.4%
0.00%
Q2 2021$0460.00%
Other shareholders
CYTOMX THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,500,000$7,635,0001.78%
Altium Capital Management LP 1,233,642$6,279,0001.65%
RA Capital Management 3,500,000$17,815,0000.25%
Soleus Capital Management, L.P. 261,050$1,329,0000.21%
Affinity Asset Advisors, LLC 125,000$636,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 1,078,103$5,488,0000.16%
Point72 Asset Management, L.P. 6,303,025$32,082,0000.14%
GSA CAPITAL PARTNERS LLP 249,146$1,268,0000.13%
Candriam S.C.A. 3,305,940$16,826,0000.11%
RTW INVESTMENTS, LP 1,400,939$7,131,0000.11%
View complete list of CYTOMX THERAPEUTICS INC shareholders